KLK3 and posterior cortical atrophy: Furthermore, as strongly recommended by the European Association of Urology (EAU) guidelines on PCa active surveillance, in case of PSA progression or change in DRE or MRI findings, it is not suggested to progress to active treatment without a repeat biopsy [5,6].